The Food and Drug Law Institute annual conference will be held on December 12-13, 2012 in Washington, DC. The two- day conference welcomes attorneys, litigators, regulators, compliance experts, consultants, and academics in the drug, medical devices, biologics, food...
Pearl Pathways’ co-founder and COO, Gretchen Miller Bowker, will be leading a discussion presented by ASQ Biomedical Division covering the similarities and differences between INDs and IDEs and everything in between. The discussion will be held at the...
A group of bipartisan senators introduced a plan to streamline the FDA’s regulation that would speed up the process of taking innovations to the market and encourage innovation. The bill would also focus on restoring balance to the conflict of interest...
Today, we announced some very exciting news. Pearl IRB has grown. To meet the needs of our clients, we have expanded our service offerings. Pearl Pathways, the new parent company, will be organized into three distinct and efficient business units. Pearl IRB remains...
On September 14th, IBJ ran a great article entitled “Health regulatory leaders ready to flock to city.” This is the first time RAPS has held its annual conference, and, as such, the first time Indianapolis has hosted so many regulatory scientists in the...
Health and Human Services announced in July a proposal to improve rules protecting human research. The proposed changes can be found in an Advance Notice of Proposed Rulemaking (ANPRM), Human Subjects Research Protections: Enhancing Protections for Research Subjects...
